A phase IV, prospective. multicenter, open-label, mother-milk study to evaluate ofatumumab concentration in the breast milk of lactating women with relapsing forms of multiple sclerosis receiving ofatumumab (Kesimpta)
Details
Age
Child to Adult
Locations
Department Specific Free Standing Clinic
University of Colorado Hospital
Principal Investigator
Anna Shah
Study ID
Protocol Number: 24-0607
More information available at ClinicalTrials.gov: NCT06444113
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers